rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    ARDX
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      ARDX UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Ardelyx (NASDAQ: ARDX) Investors of Securities Class Action Lawsuit Deadline on November 16, 2026
      Nov 11MorningstarARDX
      Ardelyx (ARDX) Stock Looks Cheap Relative To Its Sales Base

      Ardelyx has given long term holders a very different ride from what the recent slump suggests, with a strong multi year return sitting beside a sharp pullback this year. That mix of outcomes puts the spotlight on one thing for anyone looking at the stock today: whether the current share price is adequately backed by the company’s sales. Over the past 5 years, Ardelyx has delivered a 156.8% gain, which makes the current drawdown more important for judging how much of that share price move its...

      Nov 4Yahoo FinanceARDX
      Ardelyx (ARDX) Results And IBSRELA Progress Put Its Valuation Story Back In Focus

      Ardelyx (ARDX) just paired fresh third quarter 2026 results with progress in its IBSRELA pipeline, giving investors new numbers on current operations alongside an update on its late stage ACCEL trial. That progress has arrived against a tougher tape for Ardelyx, with the share price down 38.3% over the past 90 days and year to date off 50.7%, even though the 5 year total shareholder return is still positive at 156.8%. This shows that long term holders have seen gains, while recent momentum...

      Nov 4Yahoo FinanceARDX
      Ardelyx (ARDX) Q3 2026 Earnings Call Transcript

      Motley Fool Press Release.

      Nov 4The Globe and MailARDX
      ARDX Deadline Alert: Levi & Korsinsky Reminds Ardelyx, Inc. (ARDX) Investors of Securities Class Action Deadline on November 16, 2026
      Nov 4MorningstarARDX
      Ardelyx: 3 Key Takeaways for Long-Term Investors | The Motley Fool

      Doubling the field reimbursement team targets prior authorization friction, a hurdle that can stall prescriptions even after demand is established.

      Nov 4The Motley FoolARDX
      Ardelyx: Upgrading To Hold After Q3, But Risks Still Dominate (NASDAQ:ARDX)
      Nov 4Seeking AlphaARDX
      Ardelyx Inc (ARDX) (Q3 2026) Earnings Call Highlights: Revenue Climbs 19% as IBSRELA Shines and ...

      Ardelyx Inc (ARDX) posted $125.5 million in Q3 2026 product revenue on 23% IBSRELA growth, narrowed its net loss to $700,000, and reaffirmed full-year guidance while targeting profitability in 2027.

      Nov 4Yahoo FinanceARDX
      What Ardelyx (ARDX) Said on Its Q3 Earnings Call

      Ardelyx (NASDAQ:ARDX) reported third-quarter product revenue of $125.5 million, up 19% from the prior-year period, as growth in its IBS-C treatment IBSRELA offset more modest revenue growth for dialysis-focused drug XPHOZAH. President and Chief Executive Officer Mike Raab said the company’s two fir

      Nov 4Yahoo FinanceARDX
      Earnings call transcript: Ardelyx tops growth goals in Q3 2026 as stock jumps
      Nov 3Investing.comARDX
      Ardelyx Q3 2026 Earnings Call Transcript
      Nov 3BenzingaARDX
      Ardelyx (ARDX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
      Nov 3Yahoo FinanceARDX
      Ardelyx: Q3 Earnings Snapshot
      Nov 3Yahoo FinanceARDX
      Ardelyx (ARDX) Reports Break-Even Earnings for Q3
      Nov 3Yahoo FinanceARDX
      Ardelyx Reports Third Quarter 2026 Financial Results and Provides Business Update
      Nov 3Yahoo FinanceARDX
      Ardelyx completes enrollment in constipation drug trial
      Nov 3Investing.comARDX
      BTIG Remains a Buy on Ardelyx (ARDX)

      Tipranks Press Release.

      Nov 3The Globe and MailARDX
      Ardelyx Deadline: ARDX Investors with Losses in Excess of $100K Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit
      Oct 31MorningstarARDX
      Ardelyx: Revisiting The Thesis 2 Years On, I'm Surprised At Lack Of Progress (NASDAQ:ARDX)
      Oct 30Seeking AlphaARDX
      Kaplan Fox Urges Ardelyx, Inc. (NASDAQ: ARDX) Investors to Contact the Firm Before the Deadline on November 16, 2026

      NewMediaWire Press Release.

      Oct 28The Globe and MailARDX
      ARDX Stock Drop - Robbins LLP Reminds Investors They May Be Eligible to Lead the Ardelyx, Inc. Class Action Lawsuit

      Newsfile Press Release.

      Oct 26The Globe and MailARDX
      Ardelyx presents real-world data on XPHOZAH for hyperphosphatemia
      Oct 23Investing.comARDX
      Ardelyx Presents Real-World Data at ASN Kidney Week 2026 Showing Serum Phosphate Reductions Following XPHOZAH® (tenapanor) Initiation With or Without Phosphate Binders
      Oct 23Yahoo FinanceARDX
      ARDX Shareholder Alert: November 16, 2026 Lead Plaintiff Deadline in Ardelyx, Inc. Securities Class Action - Contact SueWallSt
      Oct 22MorningstarARDX
      Ardelyx to Report Third Quarter 2026 Financial Results on November 3, 2026
      Oct 20Yahoo FinanceARDX
      Wedbush Cuts Price Target on Ardelyx to $8 From $9, Keeps Outperform Rating
      Oct 19Yahoo FinanceARDX
      Kaplan Fox Continues to Remind Ardelyx, Inc. (NASDAQ: ARDX) Investors of the Lead Plaintiff Deadline on November 16, 2026
      Oct 16BarchartARDX
      ARDX Shareholder Alert: Ardelyx, Inc. Securities Class Action Lawsuit - Investors Should Contact SueWallSt
      Oct 15MorningstarARDX
      ARDX Stockholders Have Rights - If You Lost Money Investing in Ardelyx, Inc. Contact Robbins LLP for Information About Recovering Your Losses
      Oct 14MorningstarARDX
      ARDX DEADLINE: Levi & Korsinsky Reminds Ardelyx, Inc. Investors of Upcoming Securities Class Action Deadline
      Oct 14MorningstarARDX
      Kaplan Fox Continues to Alert Investors of a Securities Class Action Deadline on November 16, 2026 Against Ardelyx, Inc. (NASDAQ: ARDX)
      Oct 14BarchartARDX
      ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit
      Oct 12MorningstarARDX
      Kaplan Fox Continues to Alert Investors of Ardelyx, Inc. (NASDAQ: ARDX) to a Class Action Deadline on November 16, 2026

      NewMediaWire Press Release.

      Oct 12The Globe and MailARDX
      Ardelyx reports drop in healthcare visits after IBS-C treatment
      Oct 12Investing.comARDX
      Ardelyx Presents Real-World Data at ACG 2026 Showing Reduced Healthcare Resource Utilization Following IBSRELA® Initiation in Adults with IBS-C
      Oct 12Yahoo FinanceARDX
      Kaplan Fox Encourages Ardelyx, Inc. (NASDAQ: ARDX) Investors Seeking Recovery to Contact the Firm Before November 16, 2026
      Oct 8BarchartARDX
      SueWallSt Reminds Ardelyx, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 16, 2026 - ARDX
      Oct 8MorningstarARDX
      ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit
      Oct 7MorningstarARDX
      Ardelyx to present hyperphosphatemia research at ASN meeting
      Oct 5Investing.comARDX
      Ardelyx to Present New Data on Hyperphosphatemia Management at ASN Kidney Week 2026
      Oct 5Yahoo FinanceARDX
      Kaplan Fox Encourages Ardelyx, Inc. (NASDAQ: ARDX) Investors to Contact the Firm Before the Lead Plaintiff Deadline on November 16, 2026
      Oct 2BarchartARDX
      ARDX Deadline Alert: SueWallSt Reminds Ardelyx, Inc. (ARDX) Investors of Securities Class Action Deadline on November 16, 2026
      Oct 1MorningstarARDX
      ARDX UPCOMING DEADLINE: Levi & Korsinsky Alerts Ardelyx, Inc. Stockholders of Securities Class Action - Contact the Firm
      Sep 30MorningstarARDX
      Ardelyx Earns Multiple Honors at the 2026 PM360 Trailblazer Awards

      Recognition includes Life Sciences Manufacturer CEO of the Year, Podcast Initiative, and Marketing Team of the YearWALTHAM, Mass., Sept. 30, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today announced that it received multiple honors at the 2026 PM360 Trailblazer Awards, recognizing the company, its leadership, and the work of

      Sep 30Yahoo FinanceARDX
      Kaplan Fox Encourages Investors of Ardelyx, Inc. (NASDAQ: ARDX) to Contact the Firm Before Lead Plaintiff Deadline on November 16, 2026

      Detailed price information for Ardelyx Inc (ARDX-Q) from The Globe and Mail including charting and trades.

      Sep 30The Globe and MailARDX
      Kaplan Fox Encourages Investors of Ardelyx, Inc. (NASDAQ: ARDX) to Contact the Firm to Learn About Their Legal Rights
      Sep 25BarchartARDX
      SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of November 16, 2026 in Ardelyx, Inc. Lawsuit - ARDX
      Sep 24MorningstarARDX
      Ardelyx Targets $500M Revenue This Year, Profitability by 2027
      Sep 21Yahoo FinanceARDX
      Ardelyx Q2 2026 Earnings Call Transcript
      Sep 18BenzingaARDX
      Ardelyx at Morgan Stanley conference: growth plan meets payer pressure
      Sep 16Investing.comARDXMS

      This is the newest page. Registered accounts read further back.